REG - 3i Group PLC - Group Finance Director succession

3iAnnouncement

11/11/2021 07:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211111:nRSK0181Sa&default-theme=true

RNS Number : 0181S  3i Group PLC  11 November 2021

Press release
11 November 2021

Group Finance Director succession

 

3i Group PLC ("3i Group" or the "Company") announces that Julia Wilson, Group
Finance Director, has informed the Board that, after 15 years with the Group
and 13 years in her current role, she intends to retire after the AGM in June
2022. Julia will be succeeded by James Hatchley, who is currently the 3i Group
Strategy Director. James will join the Group Board and the Executive Committee
effective May 2022.

 

Julia joined 3i Group as Deputy Finance Director in 2006 and was made Group
Finance Director and a member of the Executive Committee in 2008. She became a
member of the Investment Committee in 2012.

 

James Hatchley joined 3i in 2017 as the Group's Strategy Director and has been
a member of the Investment Committee since 2019. Prior to joining 3i, James
was Chief Operating Officer of KKR in Europe and, before that, Co-CEO of Avoca
Capital. Earlier in his career, James was a corporate finance professional for
20 years, principally with Greenhill & Co. and Schroders, and is a
Chartered Accountant.

 

David Hutchison, Chairman of 3i Group, said:

"I would like to thank Julia on behalf of the Board for her outstanding
contribution over many years to the Company and the Board. We are delighted
that we have a deep pool of talent within the Company and that James will
succeed Julia as Group Finance Director. We very much look forward to his
contribution to the Board over the coming years."

 

Simon Borrows, CEO of 3i Group, said:

"Julia joined 3i in 2006 when 3i was a very different Company. She has helped
to steer 3i through both the great financial crisis of 2007-9 and the Covid
pandemic. Her part in the transformation of the Group since I was appointed as
CEO in 2012 has been significant. She will remain with us until the next AGM
which will allow for a smooth handover of responsibilities. Julia has been an
outstanding Finance Director and colleague and her experience, judgement and
common sense will be missed by us all when she does leave. After a thorough
consideration of internal and external candidates, I am pleased that James has
agreed to succeed Julia. He has already added significant value to the Group
in his current Strategy role, in his contribution to the Investment Committee
and to specific assets within the Group portfolio including Action and
Scandlines. He will bring considerable internal and external experience to his
new role."

 

-Ends-

 

 

For further information, contact:

 

 Kathryn van der Kroft               020 7975 3021

Communications Director

 Silvia Santoro                      020 7975 3258

Group Investor Relations Director

 

 

Notes to Editors

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private
Equity and Infrastructure. Its core investment markets are northern Europe and
North America. For further information, please visit: www.3i.com
(http://www.3i.com)

 

Additional information - James Hatchley

James Hatchley (54) is also the Senior Independent Director of Great Ormond
Street Hospital NHS Foundation Trust and is the Chair of the Great Ormond
Street Hospital NHS Foundation Trust Remuneration and Finance and Investment
Committees and a member of its Audit and People and Education Assurance
Committees. James is a member of the Scandlines Infrastructure ApS Board (a 3i
portfolio investment) and Chair of its Audit and Risk Committee. He qualified
as a Chartered Accountant in 1992. He holds a First Class Joint Honours degree
in Mathematics and Economics from the University of Surrey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOADGBDBUXBDGBG